BTO | XLF | BTO / XLF | |
Gain YTD | 0.524 | 9.087 | 6% |
Net Assets | 645M | 52.2B | 1% |
Total Expense Ratio | 2.01 | 0.08 | 2,512% |
Turnover | 13.00 | 3.00 | 433% |
Yield | 1.43 | 1.36 | 105% |
Fund Existence | 31 years | 27 years | - |
BTO | XLF | |
---|---|---|
RSI ODDS (%) | N/A | 1 day ago90% |
Stochastic ODDS (%) | 1 day ago90% | 1 day ago89% |
Momentum ODDS (%) | 1 day ago86% | 1 day ago73% |
MACD ODDS (%) | 4 days ago82% | 1 day ago80% |
TrendWeek ODDS (%) | 1 day ago85% | 1 day ago87% |
TrendMonth ODDS (%) | 1 day ago84% | 1 day ago79% |
Advances ODDS (%) | 5 days ago90% | 5 days ago86% |
Declines ODDS (%) | 3 days ago84% | 9 days ago79% |
BollingerBands ODDS (%) | 1 day ago90% | 1 day ago90% |
Aroon ODDS (%) | 1 day ago80% | 1 day ago86% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DXJ | 131.14 | 0.88 | +0.68% |
WisdomTree Japan Hedged Equity ETF | |||
NAUG | 28.95 | 0.10 | +0.34% |
Innovator Growth-100 Pwr Buffr ETF - Aug | |||
EMHY | 39.64 | -0.02 | -0.05% |
iShares J.P. Morgan EM High Yld Bd ETF | |||
HELX | 33.14 | -0.25 | -0.76% |
Franklin Genomic Advancements ETF | |||
FRTY | 22.17 | -0.35 | -1.56% |
Alger Mid Cap 40 ETF |
A.I.dvisor tells us that BTO and BAC have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BTO and BAC's prices will move in lockstep.
Ticker / NAME | Correlation To BTO | 1D Price Change % | ||
---|---|---|---|---|
BTO | 100% | +0.44% | ||
BAC - BTO | 24% Poorly correlated | +1.67% | ||
USB - BTO | 23% Poorly correlated | +0.09% | ||
FITB - BTO | 20% Poorly correlated | +1.31% | ||
HBAN - BTO | 15% Poorly correlated | +0.85% | ||
BPOP - BTO | 15% Poorly correlated | +2.09% | ||
More |
A.I.dvisor indicates that over the last year, XLF has been closely correlated with GS. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLF jumps, then GS could also see price increases.